Heterocyclic GABA A subtype selective receptor modulators

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S184000

Reexamination Certificate

active

07432283

ABSTRACT:
This invention relates to a method for modulating α2subtype GABAAreceptors with heterocyclic compounds of formula I, and salts, solvates and prodrugs thereof. The invention further relates to novel heteocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain

REFERENCES:
patent: 5668145 (1997-09-01), Bright
patent: 5705646 (1998-01-01), Bright et al.
patent: 5712303 (1998-01-01), Faraci et al.
patent: 5760225 (1998-06-01), Yuan
patent: 6200979 (2001-03-01), Bright et al.
patent: 6821984 (2004-11-01), Loughhead et al.
patent: 7053103 (2006-05-01), Loughhead et al.
patent: 2003/0187014 (2003-10-01), Uehikawa et al.
patent: WO 01/44244 (2001-06-01), None
patent: WO 03/048160 (2003-06-01), None
West, Anthony R., Solid State Chemistry and Its Applications, Wiley, New York, 1988, 358.
Wolff, Manfred E., Burger's Medicinal Chemistry and Drug Discovery, Fifth Ed., vol. 1: Principles and Practice, John Wiley & Sons, 1995, 975.
Banker, Gilbert S. et al., Modem Pharmaceutics, Marcel Dekker, New York, 1996.
Hehemann, et al., “Addition of Diamines to Methylthiopyridones,”J. Heterocyclic Chem., (1994), pp. 393-396, vol. 31 (2).
Mohareb, et al., “Reactions with 4-Phenyl-3-thiosemicarbazide: A New Approach for the Synthesis of Pyrazole, Thiazole, Pyridine and Pyrazolo[3,4-b]-Pyridine Derivatives,”Sulfur Letters, (1991), pp. 101-113, vol. 13(3).
Thompson, et al. “Tracazolate Reveals a Novel Ty[e of Allosteric Interactioin with Recombinanty-Aminobutyric AcidAeceptors,” (Apr. 2002), pp. 861-869, vol. 61:4.
Cooke, et al., “α-Subunit selective modulators of GABAAreceptor function as CNS therapeutics,” (Oct. 2002), pp. 1491-1501, vol. 12:10.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic GABA A subtype selective receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic GABA A subtype selective receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic GABA A subtype selective receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4014155

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.